Results From European Randomized Controlled Study Using XVIVO's Heart Technology Published in The Lancet

GOTHENBURG, SWEDEN / ACCESSWIRE / August 16, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, the results of the European randomized controlled clinical trial investigating the use of XVIVO's heart technology were published in the …
Jetzt den vollständigen Artikel lesen